Cimpress outlines path to $600M EBITDA by FY28 with elevated products and cost reductions

Keane projected a "path to FY '28 EBITDA of at least $600 million, coupled with very significant delevering on our balance sheet," attributing anticipated gains to ongoing cost reductions, ...